PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Symptom | |chronic infection |
| Sentences | 332 |
| PubMedID- 23910648 | chronic infection with the hepatitis b virus (hbv) is a frequent cause of cirrhosis and liver cancer. |
| PubMedID- 23114628 | chronic infection with hepatitis c virus (hcv) is a major contributor to the high and rising incidence of hepatocellular carcinoma (hcc) worldwide (chen & morgan, 2006). |
| PubMedID- 24555665 | Worldwide more than 350 million subjects have chronic infection with hepatitis b virus (hbv) and around 15–20 million people are coinfected with hepatitis d virus (hdv) 1. |
| PubMedID- 22537438 | Recently developed drugs and innovative strategies for the treatment of chronic infection with genotype 1 hepatitis c virus (hcv) have become the standard of care. |
| PubMedID- 22028694 | The incidence of hcc is increasing worldwide, mainly due to the spread of chronic infections with hepatitis b and c viruses (okuda, 2000; liovet et al., 2003; el-serag and rudolph, 2007). |
| PubMedID- 23602852 | chronic infections with hepatitis b virus (hbv) and hepatitis c virus (hcv) are highly prevalent worldwide, causing significant liver disease and thus representing high unmet medical needs. |
| PubMedID- 25622780 | chronic infection with hepatitis b virus (hbv) often leads to the development of liver cancer and cirrhosis, creating immense sociological, clinical and economic burdens worldwide. |
| PubMedID- 21573166 | Among the well known risk factors for hcc, chronic infection with hepatitis b (hbv) or c (hcv) virus is present in more than 85% of primary liver cancers 1. |
| PubMedID- 23990707 | chronic infection with the hepatitis b virus (hbv) is associated with cirrhosis, hepatic decompensation, and hepatocellular carcinoma. |
| PubMedID- 26226632 | Several risk factors have been identified to contribute to the international burden of hcc such as chronic infection with hepatitis b virus (hbv) and hepatitis c virus (hcv), alcoholic liver disease, non-alcoholic steato-hepatitis (nash), diabetes mellitus (dm), obesity, intake of aflatoxins-contaminated food, tobacco smoking, excessive alcohol drinking and genetically inherited disorders (hemochromatosis, α-1 anti-trypsin deficiency, porphyrias) 2. |
| PubMedID- 24179516 | The most common risk factors for hcc are chronic infection with hepatitis b virus or hepatitis c virus. |
| PubMedID- 24159587 | The etiology of hcc is diverse; however, approximately 80% of hccs occur secondary to chronic infection with hepatitis b virus (hbv) and/or hepatitis c virus (hcv) 4. |
| PubMedID- 26464754 | chronic infection with hepatitis delta virus (hdv) has lately regained clinical importance because of the recent evidence of increasing prevalence in several european countries, due to immigration from highly endemic areas. |
| PubMedID- 23400006 | A major risk factor is chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv)8. |
| PubMedID- 20592891 | Apart from clonorchiasis, a main risk factor of cca, the other known risk factors include chronic infection with hepatitis b and c viruses (hbv and hcv), liver cirrhosis, chronic non-alcoholic liver disease, obesity and hepatolithiasis (4, 20, 21). |
| PubMedID- 24007864 | chronic infection with hepatitis b and hepatitis c viruses are two of most common causes of liver cancer. |
| PubMedID- 24114816 | Background and rationale: chronic infection with the hepatitis c virus (hcv) is associated with a higher prevalence of insulin resistance compared to the general population. |
| PubMedID- 23323209 | The world health organization has estimated that the prevalence of chronic infections with hepatitis b virus (hbv) and hepatitis c virus (hcv) is more than 5% of the world population. |
| PubMedID- 22242973 | Introduction: the nucleotide analogue adefovir dipivoxil (adv) was approved in 2002 for the treatment of chronic infection with hepatitis b virus (hbv), in both hepatitis b e antigen (hbeag)-positive and -negative patients. |
| PubMedID- 23166535 | chronic infection with hepatitis b virus (hbv) and hepatitis c virus (hcv) accounts for about 75–80% of hcc cases worldwide (2). |
| PubMedID- 21326840 | chronic infection with hepatitis c virus is estimated to affect almost 4 million people in the usa, 5 million in europe, and 170 million worldwide 1. |
| PubMedID- 23436024 | chronic infection with hepatitis b (hbv) or c (hcv) virus, which currently affect approximately 7 % of the world population, is encountered with the same frequency among patients with arthritis starting biological or non-biological disease-modifying anti-rheumatic drugs (dmards). |
| PubMedID- 25476473 | During the interview reported treatment of chronic infection with hepatitis c virus (hcv) with peginterferon and ribavirin. |
| PubMedID- 26020957 | The onset and progression of hcc is related to risk factors such as chronic infection with hepatitis b and c viruses and exposure to hepatocarcinogen aflatoxin b1 1. |
| PubMedID- 23213046 | chronic infection with the human hepatitis b virus (hbv) is a global health problem and a main cause of progressive liver diseases. |
| PubMedID- 24461059 | chronic infection with hepatitis b virus (hbv) and exposure to aflatoxin b1 (afb1) induces p53 mutations in hepatocellular carcinoma (hcc) tissue. |
| PubMedID- 24822024 | chronic infection with hepatitis c virus (hcv) affects more than 170 million people worldwide and is a leading cause of anticipated liver-related death due to the development of cirrhosis and its complications.1 in the last 10 years, standard of care anti-hcv treatment has been founded on the combination of peginterferon (peg-ifn) plus ribavirin (rbv), whose main disadvantages were suboptimal rates of sustained virological response (svr) in difficult-to-treat patients (hcv genotype 1–4, advanced liver fibrosis) and, most of all, side effects profile resulting in poor tolerability and treatment contraindication in some patient subsets (decompensated liver disease and autoimmune disorders).2 the recent availability of culture cell models provided deeper insight in understanding hcv life cycle and was the basis for the development of new drugs targeting non-structural hcv proteins involved in viral replication process, such as ns3 and ns5a/b (figure 1 and table 1). |
| PubMedID- 20513077 | Case report: cure of chronic infection with hepatitis c virus after 6 weeks of peg-interferon and ribavirin in a patient co-infected with hiv. |
| PubMedID- 25757614 | chronic infection with hepatitis b virus (hbv) occurs in approximately 5 % of the world's human population and persistence of the virus is associated with serious complications of cirrhosis and liver cancer. |
| PubMedID- 20198633 | chronic infection with hepatitis b virus (hbv) is strongly associated with hepatocellular carcinoma (hcc), and the viral hbx protein plays a crucial role in the pathogenesis of liver tumors. |
| PubMedID- 23162603 | The geographic variation in hcc incidence might be due to geographic differences in the prevalence of various etiological factors, particularly chronic infection with hepatitis b and/or c virus, and dietary exposure to aflatoxins (2). |
| PubMedID- 25013557 | chronic infection with hepatitis c virus (hcv) continues to be the most common indication for orthotopic liver transplantation (olt) in the united states and western europe. |
| PubMedID- 25557114 | In addition, some pathological factors that contribute to the activation of foxm1, such as chronic infection with hepatitis b virus, are also risk factors for hcc recurrence24. |
| PubMedID- 26075599 | chronic infection with hepatitis c virus (hcv) is known as the major agent of chronic liver disease, hepatic cirrhosis, and hepatocellular carcinoma. |
| PubMedID- 26186636 | chronic infection with the hepatitis c virus (hcv) is a cause of cirrhosis and hepatocellular carcinoma worldwide. |
| PubMedID- 25099228 | chronic infection with hepatitis b virus (hbv) is a risk factor for developing hepatocellular carcinoma (hcc). |
| PubMedID- 20085587 | In addition, a possible association between chronic infection with hepatitis b and c viruses and cholangiocarcinoma was also noted. |
| PubMedID- 20482252 | Hbsag profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis b and c viruses. |
| PubMedID- 26034765 | Overall, liver-related death, mainly due to chronic infection with hepatitis c virus (hcv) or hepatitis b virus, represents the most frequent cause of non-aids-related death 2. |
| PubMedID- 25443339 | Due to shared routes of transmission, acute and chronic infection with hepatitis c virus is common among persons living with hiv infection in many regions of the world. |
| PubMedID- 22095619 | After adjustment for chronic infection with hepatitis b/c viruses, family history of liver cancer was associated with hcc risk, when using both the binary indicator (or, 2.38; 95% ci, 1.01-5.58) and the fhscore, with increasing ors for successive score categories. |
| PubMedID- 21183794 | chronic infection with hepatitis c virus (hcv) is a major public health problem, with nearly 170 million infected individuals worldwide. |
| PubMedID- 24211330 | End stage liver disease caused by chronic infection with the hepatitis c virus (hcv) is a leading indication for liver transplantation, yet outcomes are poor since the liver graft is rapidly re-infected by hcv. |
| PubMedID- 24719731 | Background: chronic infection with hepatitis c virus (hcv) is increasingly recognized as a major global health problem. |
| PubMedID- 21261993 | chronic infection with hepatitis b virus (hbv) or hepatitis c virus (hcv) is associated with increased morbidity and mortality. |
| PubMedID- 23071503 | chronic infection with hepatitis c virus (chcv) is present in 3% of the world’s population with prevalence ranging from 0.1–5% in different european countries 1. |
| PubMedID- 23370206 | The intersecting effects of alcohol intake, chronic infection with hepatitis b and/or c viruses, obesity and the development of insulin resistance makes understanding the exact nature of the association between diabetes and hcc difficult, though the effects of elevated insulin levels due to insulin resistance remains the most well studied effect of diabetes on hcc development. |
| PubMedID- 21461964 | chronic infections with hepatitis c virus (hcv) are frequently pronounced in the etiology of malignancies especially in hepatocellular carcinoma. |
| PubMedID- 21618261 | Background: chronic infection with hepatitis b virus and hepatitis delta virus (hdv) results in the most severe form of viral hepatitis. |
| PubMedID- 25604355 | Although chronic infection with hepatitis c virus (hcv) is the leading indication for liver transplantation in the united states, graft and patient survival rates are reduced because of hcv recurrence after transplant. |